Senores Pharmaceuticals Ltd - IPO

Senores Pharmaceuticals Ltd IPO Details

Initial public offering of up to [*] equity shares of face value of Rs. 10 each (Equity Shares) of Senores Pharmaceuticals Limited (The Company or the Issuer) for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) (Offer Price) aggregating up to Rs. [*] crores (the Offer). The offer comprises of a fresh issue of upto [*] equity shares by the company aggregating upto Rs. 500.00 crores (the Fresh Issue) and an offer for sale of up to 2,100,000 equity shares (the Offered Shares) aggregating up to Rs. [*] crores (the Offer for Sale), comprising up to 250,000 equity shares aggregating to Rs. [*] crores by Swapnil Jatinbhai Shah, up to 550,000 equity shares aggregating to Rs. [*] crores by Ashokkumar Vijaysinh Barot, up to 300,000 equity shares aggregating to Rs. [*] crores by Sangeeta Mukur Barot and up to 1,000,000 equity shares aggregating to Rs. [*] crores by Prakash M Sanghvi (the Selling Shareholders). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of up to 75,000 equity shares, aggregating up to Rs. [*] crores (constituting [*] of the post-offer paid-up equity share capital, for subscription by eligible employees (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. Price Band: Rs. 372 to Rs. 391 per equity share of face value of Rs. 10 each.The Floor price is 37.20 times the face value of the equity shares and cap price is 39.10 times the face value of the equity shares.Bid can be made for a minimum of 38 equity shares and in multiples of 38 equity shares.

Objective of issue

Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility. Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI. Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris. Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes. Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries. Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements.

Senores Pharmaceuticals Ltd Contact Details

Senores Pharmaceuticals Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083

Phone - 91-22-49186000

Fax - 91-22-49186060

Email - cs@senorespharma.com

Website - www.senorespharma.com